Your browser doesn't support javascript.
loading
Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib / 한국유방암학회지
Journal of Breast Cancer ; : 100-106, 2020.
Article in English | WPRIM | ID: wpr-811192
ABSTRACT
Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia. However, hematological malignancies have not been reported for palbociclib treatment. Here, for the first time, we present a case of acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment with letrozole and palbociclib for metastatic breast cancer. This case emphasizes the need for long term follow up of patients treated with palbociclib.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Breast Neoplasms / Follow-Up Studies / Hematologic Neoplasms / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Leukopenia / Neutropenia Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Journal of Breast Cancer Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Breast Neoplasms / Follow-Up Studies / Hematologic Neoplasms / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Leukopenia / Neutropenia Type of study: Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Journal of Breast Cancer Year: 2020 Type: Article